Novo Nordisk A/S

Healthcare · Drug Manufacturers - General · Denmark

Last price 39.14 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 171.97B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Pl...